Evidence map›Paper›PMID 25932631›Full record

ArticlePloS one2015

The Structure of the T190M Mutant of Murine α-Dystroglycan at High Resolution: Insight into the Molecular Basis of a Primary Dystroglycanopathy.

Manuela Bozzi, Alberto Cassetta, Sonia Covaceuszach, Maria Giulia Bigotti, Saskia Bannister, Wolfgang Hübner, Francesca Sciandra, Doriano Lamba, Andrea Brancaccio

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Cytoplasmic region of beta-dystroglycan is essential for postsynaptic maturation and neuromuscular function in mice.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Protective role for the N-terminal domain of α-dystroglycan in Influenza A virus proliferation.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  7. A molecular overview of the primary dystroglycanopathies.Journal of cellular and molecular medicine · 2019
    Review
  8. Article
  9. Expansion of divergent SEA domains in cell surface proteins and nucleoporin 54.Protein science : a publication of the Protein Society · 2017
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Manuela BozziIstituto di Biochimica e Biochimica Clinica, Università Cattolica del Sacro Cuore, Roma 00168, Italy.
Alberto CassettaIstituto di Cristallografia-CNR, Trieste Outstation, Trieste, 34149, Italy.
Sonia CovaceuszachIstituto di Cristallografia-CNR, Trieste Outstation, Trieste, 34149, Italy.
Maria Giulia BigottiSchool of Biochemistry, University of Bristol, Bristol, BS8 1TD, United Kingdom.
Saskia BannisterDepartment of Physics, University of Bielefeld, 33615, Bielefeld, Germany.
Wolfgang HübnerDepartment of Physics, University of Bielefeld, 33615, Bielefeld, Germany.
Francesca SciandraIstituto di Chimica del Riconoscimento Molecolare-CNR, c/o Università Cattolica del Sacro Cuore, Roma, 00168, Italy.
Doriano LambaIstituto di Cristallografia-CNR, Trieste Outstation, Trieste, 34149, Italy.
Andrea BrancaccioSchool of Biochemistry, University of Bristol, Bristol, BS8 1TD, United Kingdom; Istituto di Chimica del Riconoscimento Molecolare-CNR, c/o Università Cattolica del Sacro Cuore, Roma, 00168, Italy.

Funding

Wellcome Trust
6 · The paper itself

Abstract

The severe dystroglycanopathy known as a form of limb-girdle muscular dystrophy (LGMD2P) is an autosomal recessive disease caused by the point mutation T192M in α-dystroglycan. Functional expression analysis in vitro and in vivo indicated that the mutation was responsible for a decrease in posttranslational glycosylation of dystroglycan, eventually interfering with its extracellular-matrix receptor function and laminin binding in skeletal muscle and brain. The X-ray crystal structure of the missense variant T190M of the murine N-terminal domain of α-dystroglycan (50-313) has been determined, and showed an overall topology (Ig-like domain followed by a basket-shaped domain reminiscent of the small subunit ribosomal protein S6) very similar to that of the wild-type structure. The crystallographic analysis revealed a change of the conformation assumed by the highly flexible loop encompassing residues 159-180. Moreover, a solvent shell reorganization around Met190 affects the interaction between the B1-B5 anti-parallel strands forming part of the floor of the basket-shaped domain, with likely repercussions on the folding stability of the protein domain(s) and on the overall molecular flexibility. Chemical denaturation and limited proteolysis experiments point to a decreased stability of the T190M variant with respect to its wild-type counterpart. This mutation may render the entire L-shaped protein architecture less flexible. The overall reduced flexibility and stability may affect the functional properties of α-dystroglycan via negatively influencing its binding behavior to factors needed for dystroglycan maturation, and may lay the molecular basis of the T190M-driven primary dystroglycanopathy.

Indexed as

Models, MolecularAnimalsCell Line, TumorDystroglycansHumansHydrogen BondingMiceMicroscopyMuscular Dystrophies, Limb-GirdleMutant ProteinsProtein StabilityProtein Structure, TertiaryX-Ray DiffractionDystroglycansMutant Proteins

Identifiers

PMID25932631
PMCPMC4416926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.